Literature DB >> 31434100

Stroke Factors Associated with Thrombolysis Use in Hospitals in Singapore and US: A Cross-Registry Comparative Study.

Sheryl Hui-Xian Ng1, Alex W K Wong2, Cynthia Huijun Chen1, Chuen Seng Tan1, Falk Müller-Riemenschneider1,3, Bernard P L Chan4, M Carolyn Baum2, Jin-Moo Lee5, Narayanaswamy Venketasubramanian6, Gerald Choon-Huat Koh7.   

Abstract

BACKGROUND AND OBJECTIVES: This paper aims to describe and compare the characteristics of 2 stroke populations in Singapore and in St. Louis, USA, and to document thrombolysis rates and contrast factors associated with its uptake in both populations.
METHODS: The stroke populations described were from the Singapore Stroke Registry (SSR) in -Singapore and the Cognitive Rehabilitation Research Group Stroke Registry (CRRGSR) in St. Louis, MO, USA. The registries were compared in terms of demographics and stroke risk factor history. Logistic regression was used to determine factors associated with thrombolysis uptake.
RESULTS: A total of 39,323 and 8,106 episodes were recorded in SSR and CRRGSR, respectively, from 2005 to 2012. Compared to CRRGSR, patients in SSR were older, male, and from the ethnic majority. Thrombolysis rates in SSR and CRRGSR were 2.5 and 8.2%, respectively, for the study period. History of ischemic heart disease or atrial fibrillation was associated with increased uptake in both populations, while history of stroke was associated with lower uptake. For SSR, younger age and males were associated with increased uptake, while having a history of smoking or diabetes was associated with decreased uptake. For CRRGSR, ethnic minority status was associated with decreased uptake.
CONCLUSIONS: The comparison of stroke populations in Singapore and St Louis revealed distinct differences in clinicodemographics of the 2 groups. Thrombolysis uptake was driven by nonethnicity demographics in Singapore. Ethnicity was the only demographic driver of uptake in the CRRGSR population, highlighting the need to target ethnic minorities in increasing access to thrombolysis.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  International comparison; Stroke; Thrombolysis; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31434100      PMCID: PMC6759403          DOI: 10.1159/000502278

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  22 in total

1.  Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study.

Authors:  Amie W Hsia; Dorothy F Edwards; Lewis B Morgenstern; Jeffrey J Wing; Nina C Brown; Regina Coles; Sarah Loftin; Andrea Wein; Sara S Koslosky; Sabiha Fatima; Brisa N Sánchez; Ali Fokar; M Chris Gibbons; Nawar Shara; Annapurni Jayam-Trouth; Chelsea S Kidwell
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

2.  Time trends in systemic thrombolysis in a large hospital-based stroke registry.

Authors:  O C Singer; G F Hamann; B Misselwitz; H Steinmetz; C Foerch
Journal:  Cerebrovasc Dis       Date:  2012-02-15       Impact factor: 2.762

3.  The impact of smoking on the severity of acute ischemic stroke.

Authors:  Wei-Chieh Weng; Wen-Yi Huang; Yu-Yi Chien; Chia-Lun Wu; Feng-Chieh Su; Heng Jung Hsu; Tsong-Hai Lee; Tsung-I Peng
Journal:  J Neurol Sci       Date:  2011-06-12       Impact factor: 3.181

4.  Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke.

Authors:  Deena M Nasr; Waleed Brinjikji; Harry J Cloft; Alejandro A Rabinstein
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-11       Impact factor: 2.136

5.  Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.

Authors:  Lee H Schwamm; Syed F Ali; Mathew J Reeves; Eric E Smith; Jeffrey L Saver; Steven Messe; Deepak L Bhatt; Maria V Grau-Sepulveda; Eric D Peterson; Gregg C Fonarow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-01

Review 6.  Gender issues in acute stroke thrombolysis.

Authors:  D A De Silva; M Ebinger; S M Davis
Journal:  J Clin Neurosci       Date:  2009-02-06       Impact factor: 1.961

7.  Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas
Journal:  Stroke       Date:  2013-01-31       Impact factor: 7.914

Review 8.  Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis.

Authors:  Mathew Reeves; Archit Bhatt; Peter Jajou; Michael Brown; Lynda Lisabeth
Journal:  Stroke       Date:  2009-02-19       Impact factor: 7.914

9.  Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

Review 10.  How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.

Authors:  Christine L Paul; Annika Ryan; Shiho Rose; John R Attia; Erin Kerr; Claudia Koller; Christopher R Levi
Journal:  Implement Sci       Date:  2016-04-08       Impact factor: 7.327

View more
  1 in total

Review 1.  Recovery from stroke: current concepts and future perspectives.

Authors:  Christian Grefkes; Gereon R Fink
Journal:  Neurol Res Pract       Date:  2020-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.